Dominion Energy is the kind of stable utility stock that's great to own during turbulent markets. Enbridge has a lower risk ...

Charles Kim Haskell told Newsweek he once thought he wouldn't live beyond his teenage years, but, at 31, he is enjoying his life.

A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...

The number of advancements occurring in the medical community every year are astounding. For instance, there’s now ...

The Victor Phillip Dahdaleh Heart & Lung Research Institute is a thriving community of scientists and clinicians, the largest ...

Vertex Pharmaceuticals secured European approval for Alyftrek, reinforcing its dominance in cystic fibrosis treatment as ...

He’ll enter an elite portal of local baseball history on the strength of a dastardly secondary pitch. Left-hander Jamie Arnold’s slider, launched from a sneaky arm slot, is a cunning composite of ...

In a paper published last month, researchers at UT Southwestern Medical Center introduced lipid nanoparticles — hollow, fatty ...

Individuals with cystic fibrosis or CFTR gene variants have a 3-fold higher risk of developing pancreatic cancer after 50 years of age.

The biotech is taking inspiration from cystic fibrosis treatment and applying a similar approach to developing "corrector" ...

Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.

This shift follows the announcement of initial positive data from the Phase 1/2 clinical trial of PM359 in Chronic ...